Seqirus lobbying for Seqirus

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Expenses

$250,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

New Jersey

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Budget/Appropriations

FY2025 Appropriations, policies related to pandemic preparedness and public health; HR 5846, Protecting America from Seasonal and Pandemic Influenza Act of2023; S 3219, Influenza Act; FY2025 NDAA, issues related to influenza surveillance and vaccine development; Pandemic and All-Hazards Preparedness Reauthorization.

Health Issues

FY2025 Appropriations, policies related to pandemic preparedness and public health; HR 5846, Protecting America from Seasonal and Pandemic Influenza Act of2023; S 3219, Influenza Act; FY2025 NDAA, issues related to influenza surveillance and vaccine development; Pandemic and All-Hazards Preparedness Reauthorization.

Bills named in this filing 1

H.R. 5846
Protecting America from Seasonal and Pandemic Influenza Act of 2023